Pfizer is to invest $200m to improve the company’s biotechnology manufacturing plant in Clondalkin, County Dublin, Ireland.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The company’s Grange Castle facility will receive two new processing suites in order to expand its production and testing capacity, enhancing on the capabilities of what is already one of the world’s largest biotech facilities.

Pfizer CFO Frank D’Amelio noted that Ireland is a prime location for major investment, citing the fact that pharmaceutical and chemical products account for over 50% of Irish exports.

Pfizer currently produces two blockbuster products at the Grange Castle plant – pneumococcal disease vaccine Prevnar and arthritis medication Enbrel.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now